Everett Cunningham
Chief Executive Officer, GeneDx Holdings Corp. · United States
Everett Cunningham is the CEO of GeneDx Holdings Corp. (WGS). Cunningham is based in the United States.
Everett Cunningham is a veteran diagnostics and commercial leader with more than 35 years of experience across diagnostics, genomics, medical technology, and pharmaceuticals. He holds a bachelor's degree in economics from Northwestern University and previously served as President and CEO of Quanterix Corporation, with prior senior leadership roles at Illumina, Exact Sciences, GE Healthcare, Quest Diagnostics, and Pfizer.
Recent developments
AI summary of recent coverageRecent coverage has focused on GeneDx Holdings appointing Everett Cunningham as chief executive officer to succeed Katherine Stueland, with the transition scheduled for December 15, 2026. Cunningham, who previously served as CEO of Quanterix, received a compensation package including $20 million in stock awards. GeneDx reaffirmed its 2026 financial guidance in connection with the leadership announcement.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Everett Cunningham, it will appear here — and tie into the news timeline.
Everett Cunningham: FAQ
- Who is Everett Cunningham?
- Everett Cunningham is the Chief Executive Officer of GeneDx Holdings Corp., based in United States.
- What company does Everett Cunningham lead?
- Everett Cunningham is CEO of GeneDx Holdings Corp..